Information

New Managing Director at TWB

5 April 2019

TWB announced the appointment of Olivier Rolland, 38, as Managing Director on January 1, 2019, succeeding founder Pierre Monsan. His experience in major industry groups (Boeing, Total, Michelin) and his international experience, particularly in biotechnology and product development in San Francisco, are key assets for TWB development. Olivier Rolland, PhD in chemistry (Executive certificates from… Read more »

And the winner is TempEasy!

20 February 2019

TWB rewarded the start-up TempEasy, in the frame of the event ‘TWB START-UP DAY – From Biosciences to Bioproduction’ held in Toulouse – France, on 12 February, 2019. At each event, TWB organises a competition in which all European biotech start-ups of 5 years or more, offering differentiating and innovative solutions, may participate. This year… Read more »

Great success for TWB START-UP DAY

20 February 2019

TWB brought together nearly 180 professionals from 10 countries, among which forty were start-ups, structures for biotechs innovation and promotion, industrialists and investors. Held in Toulouse on February 12, 2019 at the Toulouse Business School (TBS), TWB START-UP DAY is set to become an international benchmark event for biotech start-ups. The goal of this event… Read more »

News of the TWB Scientific Advisory Board

13 November 2018

The TWB Scientific Advisory Board consists of 9 members who annually examine the different research projects led by TWB. During its last meeting on October in Toulouse, it welcomed a new member, Uwe T. Bornscheuer, and appointed the new chairwoman, Merja Penttilä. The Scientific Advisory Board was set up when TWB was created in 2012…. Read more »

TWB: 2 new startups hosted

22 October 2018

TWB announces the arrival of two new startups, iMEAN and Green Spot Technologies. Both fledgling firms will have access to state-of-the-art facilities, high-level expertise and an extensive network of academic and industrial biotechnology specialists. TWB supports startups by hosting them and providing workspace and a range of services. Start-up companies hosted by TWB enjoy a… Read more »

TWB & ADISSEO collaboration

2 October 2018

Adisseo and TWB confirm the success of the biological alternative for producing methionine and demonstrate the potentials of synthetic biology using a pragmatic industrial approach. Adisseo, the industrial group specialized in animal nutrition, and TWB have been partnering since 2012 to find a biological pathway for producing methionine through renewable biomass. The methionine is an… Read more »

TWB supports iGEM 2018

24 July 2018

TWB provides financial support to the iGEM University of Toulouse 2018 team and to the iGEM Institut Pasteur 2018 team. About iGEM (international Genetically Engineered Machine) The prestigious iGEM competition in synthetic biology is organized by the MIT (Massachusetts Institut of Technology). This competition aims to promote the development of synthetic biology and its teaching. Every… Read more »

Focus on industrial partnerships

12 June 2018

Laurie Rey has joined TWB in February 2018 as Head of Industrial Partnerships. Her mission is to develop TWB in France and abroad and to consolidate the TWB consortium. She is working directly with Michel Manach, Director of Industrial Partnerships. Laurie Rey is a member of TWB executive cell, its strategic and managerial body. Laurie… Read more »

TWB Activity report 2017

22 March 2018

TWB impact in the innovation process in life science applications was confirmed in 2017. With 85 collaborators at the end of 2017 and a turn-over of €8M, TWB has a stable growth. TWB attractiveness has been confirmed: 8 new industrial partners joined the consortium in 2017, leading to a total number of 53 private and… Read more »

New Partners 2018 & New President

21 March 2018

During the meeting of its Strategic Steering Committee (SSC) on 15 & 16 March, 2018, TWB welcomed 3 new industrial partners who joined the consortium on 1 January of the year: BRASKEM, IFPEN, MILLIDROP.   The consortium is now composed of 46 private and public partners (8 large companies, 1 mid-cap company, 8 small and… Read more »